Tenaya Therapeutics
TNYA · NASDAQ
$0.41+$0.0068 (+1.69%)TodayMarket closed ·
Prev close $0.4032
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 20.0% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.0697 | -$0.20 | −186.9% |
| Q1 FY26 | -$0.0889 | -$0.09 | −1.2% |
| Q4 FY25 | -$0.1237 | -$0.12 | +3.0% |
| Q3 FY25 | -$0.1507 | -$0.12 | +20.4% |
| Q2 FY25 | -$0.255 | -$0.14 | +45.1% |
| Q1 FY25 | -$0.1938 | -$0.24 | −23.8% |
| Q4 FY24 | -$0.3173 | -$0.28 | +11.8% |
| Q3 FY24 | -$0.3749 | -$0.30 | +20.0% |
Earnings calls
- H.C. Wainwright 28th Annual Global Investment Conference
- Canaccord Genuity's 46th Annual Growth Conference
- Jefferies Global Healthcare Conference 2026
- Special Call - Tenaya Therapeutics, Inc.
- Special Call - Tenaya Therapeutics, Inc.
- Leerink Global Healthcare Conference 2026
- Special Call - Tenaya Therapeutics, Inc.
- Shareholder/Analyst Call - Tenaya Therapeutics, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.